Added to YB: 2017-11-29
Pitch date: 2017-11-29
NVO:US [bullish]
Novo Nordisk A/S
+54.27%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.1T
Pitch Price
DKK 23.77
Price Target
N/A
Dividend
4.94%
EV/EBITDA
7.46
P/E
10.29
EV/Sales
3.74
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Novo Nordisk A/S Sponsored ADR Class B NVO:US
A summary for this pitch has not been created yet.
Read full article (0 min)